Status:

COMPLETED

Cost-Effectiveness Study Of The Treatment Of Attention Deficit/Hyperactivity Disorder In Brazil

Lead Sponsor:

Hospital de Clinicas de Porto Alegre

Collaborating Sponsors:

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Conditions:

Attention-deficit/Hyperactivity Disorder

Eligibility:

MALE

8-10 years

Phase:

PHASE4

Brief Summary

This study is an open-label, 6 month trial, of immediate release methylphenidate (MPH-IR) for children with ADHD aimed at assessing whether the observable behavioral changes seen during treatment are ...

Eligibility Criteria

Inclusion

  • The study will include 20 boys aged 8 to 10 years old, regularly enrolled in local schools and directed to the research through advertisement in the media, contact with schools or directly referred to the Attention Deficit/Hyperactivity Program (ProDAH/HCPA) by primary care services for assessment and treatment. Only children with a primary diagnosis of ADHD or with the comorbidity ADHD + reading disorder or ADHD + ODD will be included. Only drug-naïve subjects will be apt to participate in the study.

Exclusion

  • Children who fit into one or more of the following conditions will not be considered eligible to take part in the study: (1) they are outside the age range specified; (2) they are not regularly enrolled and attending school; (3) they have a history of prior or current treatment with psychoactive drugs or psychotherapy; (4) they are mentally retarded (Overall IQ\<80); (5) they have a main diagnosis differing from ADHD, including children with other psychiatric or neurological diagnoses

Key Trial Info

Start Date :

December 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2013

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT01228604

Start Date

December 1 2010

End Date

December 1 2013

Last Update

July 21 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital de Clinicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil, 90035903

Cost-Effectiveness Study Of The Treatment Of Attention Deficit/Hyperactivity Disorder In Brazil | DecenTrialz